Gebauer Medizintechnik GmbH

What Gebauer Medizintechnik GmbH does

Gebauer Medizintechnik GmbH is a privately held German medical device company (GmbH) operating commercially under the brand XENIA. The company designs, manufactures, and distributes custom-made XENIA corneal implants fabricated from purified, decellularized porcine corneal collagen that has been biochemically treated through a proprietary crosslinking process. It holds EU Medical Device Regulation (EU) 2017/745 approval for its implant as a custom-made device and operates an ISO 13485-certified quality management system at its manufacturing facility near Stuttgart, Germany. The two commercial indications are advanced keratoconus and post-LASIK ectasia (additive keratoplasty) and presbyopia correction via a multifocal corneal inlay approach.

The company's go-to-market is a prescription-based, sales-led model targeting ophthalmic surgeons and specialty eye clinics rather than end consumers. XENIA implants are produced on a per-patient basis against surgeon-supplied specifications, with orders placed through downloadable prescription request forms. Commercial activity is concentrated at major ophthalmology congresses including the ESCRS annual and winter meetings, the World Keratoconus Congress, Alicante Refractiva Internacional, FEMTO LENTICULAR shaping events, and CXL Experts Meetings. A XENIA Pioneers program supports early-adopter surgeons, and the company's resources library hosts surgical videos, brochures, clinical papers, and surgeon testimonials. Customer evidence is concentrated in named accounts across the United Kingdom (Optimax/Ultralase, Barts Health NHS Trust / Whipps Cross University Hospital), Egypt (Alexandria University Hospital), and Spain (Vissum Miranza Alicante), with additional reference to India.

The firm is founder-managed by Managing Director Steffen Gebauer, with John Dean serving as commercial contact and Sieglinde Raab as Data Protection Officer. The company reports only approximately 5 employees, indicating a tightly held specialty manufacturer. No external institutional funding, M&A activity, or ownership changes are evidenced in the source material, and detailed cap table information is not disclosed. Operating geographies span Europe (Germany, United Kingdom, Spain), Africa (Egypt), and Asia (India) based on documented clinical adoption, although no formal global distribution or US regulatory pathway is in evidence.

Name

Gebauer Medizintechnik GmbH

Legal name

Gebauer Medizintechnik GmbH

Website

https://xenia-implant.com

Company type

Private

Founded year

1985

Operating status

Operating

Headcount range

1–10 employees

Short description

Gebauer Medizintechnik GmbH (XENIA) is a privately held German medical device company that manufactures custom-made porcine collagen corneal implants for ophthalmic surgeons treating keratoconus, post-LASIK ectasia, and presbyopia.

Ownership category

akta.pro rank

Product category

Ophthalmic Medical Devices

NAICS

Ophthalmic Goods Manufacturing (339115), Surgical and Medical Instrument Manufacturing (339112)

SIC

Ophthalmic Goods (3851), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Cornea & External Disease Surgical Devices (Keratoplasty Tools, Cross-Linking Systems, Amniotic Membrane Delivery) (HLAHAJAK)

akta.pro secondary industries

Cornea, External Disease & Refractive Surgery (LASIK/PRK) (HLAKAKAF), Refractive Surgery Systems (Excimer/Femtosecond Lasers, Phakic IOL Systems, Wavefront/Guidance) (HLAHAJAG)

Keywords

• Custom corneal implants
• Ophthalmic medical devices
• Refractive surgery implants
• Porcine collagen implants
• Presbyopia treatment devices

Headquarters

HQ city

Neuhausen

HQ country

Germany

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Custom Corneal Implant Manufacturing: Custom-made XENIA corneal implants manufactured exclusively for individual patients based on physician prescriptions. The product is tailored to individual patient specifications for optimal visual performance.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels5 records

Core offering

Gebauer Medizintechnik GmbH manufactures and sells custom-made XENIA corneal implants made from purified natural porcine corneal collagen for ophthalmic surgeons and eye clinics. The implants are used in additive (reversible, sutureless) intrastromal keratoplasty procedures to treat presbyopia (near vision loss) and advanced keratoconus or post-LASIK ectasia. Each device is manufactured to patient-specific specifications based on physician prescription, with multifocal optics and proprietary decellularization/crosslinking.

Product overview

Gebauer Medizintechnik GmbH (operating as XENIA) offers a portfolio of custom-made corneal implants manufactured from purified natural porcine corneal collagen. The XENIA system includes two main products: the XENIA Corneal Implant for Presbyopia (for restoring near vision) and the XENIA Corneal Implant for Keratoconus (for additive keratoplasty). Both products utilize a proprietary decellularization and crosslinking process to create highly biocompatible collagen implants. The company manufactures at its facility near Stuttgart, Germany, and all products are MDR-approved custom-made devices available only by physician prescription.

Differentiator

Problem solved

Functional benefit

Brands

• XENIA Implant for Presbyopia: Custom-made corneal implant for presbyopia treatment, less than 2mm in diameter and less than 30µm in thickness, made from purified natural corneal collagen (porcine origin). Provides multifocal optics for near and distance vision.

Products and services

• XENIA Corneal Implant for Presbyopia Custom-made corneal implant made from purified natural porcine corneal collagen, designed to restore near vision and eliminate reading glasses dependency in presbyopia patients. The implant is less than 2mm in diameter and less than 30µm in thickness, implanted in a micro-invasive corneal pocket created by a femtosecond laser. Available only by physician prescription.
• XENIA Corneal Implant for Keratoconus (Additive Keratoplasty) Custom-made corneal implant for additive keratoplasty procedures used in the treatment of advanced keratoconus and post-LASIK ectasia. Made from decellularized and crosslinked porcine corneal collagen, implanted via a quick, sutureless, outpatient procedure that preserves the patient's own cornea and allows exchange or removal if required. Available only by physician prescription.

Quantifiable outcome

• Clinical follow-up data dating back to 2019 for additive keratoplasty procedures
• +3 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Johnson & Johnson Vision: Johnson & Johnson Vision provides LASIK platforms (iDesign, IntraLase), IOLs (TECNIS), and contact lens solutions — competing in both refractive vision correction and cataract surgery adjacencies to XENIA's corneal implant indications.
• Alcon: Alcon is the global ophthalmic leader with broad portfolios in cataract IOLs, refractive surgery (including presbyopia-correcting IOLs and the Vivity IOL), and surgical equipment — overlapping directly with XENIA's presbyopia and keratoconus/ectasia indications.
• Bausch + Lomb: Bausch + Lomb offers a broad ophthalmic portfolio including IOLs, refractive surgery products, and corneal health products (e.g., corneal cross-linking systems for keratoconus) — competing across multiple indications XENIA targets.
• Nidek: Nidek manufactures refractive and cataract surgery equipment including excimer and femtosecond lasers — providing the surgical platforms used by ophthalmic surgeons who also implant XENIA, and competing indirectly in the presbyopia/keratoconus treatment ecosystem.
• Carl Zeiss Meditec: Carl Zeiss Meditec is a large, diversified ophthalmic medical device company offering surgical microscopes, IOLs, refractive lasers, and consumables — providing competing solutions across the cataract, refractive, and corneal surgery workflows that XENIA also addresses.

Direct peers

• STAAR Surgical: STAAR Surgical manufactures phakic intraocular lenses (Visian ICL) for refractive vision correction — the closest direct comparator to XENIA's additive corneal implant approach, both targeting refractive surgeons and elective vision-correction patients.

Regional players

• CorneaGen: CorneaGen is a leading US corneal tissue supplier for transplantation procedures (PK, DALK) — representing the donor-tissue pathway that XENIA's additive implant is designed to displace in keratoconus and ectasia.

Emerging players

• BostonSight: BostonSight specializes in scleral lens PROSE treatment and other specialty contact lenses for keratoconus and ocular surface disease — a niche but adjacent therapeutic alternative for the keratoconus patient population XENIA targets.
• Aurion Biotech: Aurion Biotech is developing cell therapies for corneal endothelial disease — representing an emerging regenerative-medicine approach to corneal disease that may ultimately compete with or complement surgical implants like XENIA.
• Glaukos Corporation: Glaukos develops micro-invasive ophthalmic surgical implants (MIGS for glaucoma) — a comparable specialty ophthalmic implant business model targeting surgeon-customized, premium-priced interventional products with regulatory-driven moats.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/gebauer-medizintechnik-gmbh

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Gebauer Medizintechnik GmbH